| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF737 SP5 SP9 SP8 ZNF677 ZNF444 ZNF600 ZNF773 ZNF84 ZNF841 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 ZNF835 SP7 ZNF189 | 1.23e-12 | 1244 | 42 | 19 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF737 SP5 SP9 SP8 ZNF677 ZNF444 ZNF600 ZNF773 ZNF84 ZNF841 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 ZNF835 SP7 ZNF189 | 1.80e-12 | 1271 | 42 | 19 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF787 ZNF737 SP5 SP9 SP8 ZNF677 ZNF444 ZNF600 ZNF773 ZNF84 ZNF841 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 SP7 ZNF189 | 1.14e-11 | 1412 | 42 | 19 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF737 SP5 SP9 SP8 ZNF677 ZNF444 ZNF600 ZNF773 ZNF84 ZNF841 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 ZNF835 SP7 ZNF189 | 2.02e-11 | 1459 | 42 | 19 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.05e-03 | 560 | 42 | 6 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.11e-03 | 566 | 42 | 6 | GO:0001216 | |
| Domain | - | ZNF787 ZNF737 SP5 SP9 SP8 ZNF677 ZNF444 ZNF600 ZNF773 ZNF84 ZNF841 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 ZNF835 SP7 ZNF189 | 1.63e-18 | 679 | 41 | 20 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF787 ZNF737 SP5 SP9 SP8 ZNF677 ZNF444 ZNF600 ZNF773 ZNF84 ZNF841 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 ZNF835 SP7 ZNF189 | 2.42e-18 | 693 | 41 | 20 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF787 ZNF737 SP5 SP9 SP8 ZNF677 ZNF444 ZNF600 ZNF773 ZNF84 ZNF841 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 ZNF835 SP7 ZNF189 | 2.49e-18 | 694 | 41 | 20 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF787 ZNF737 SP5 SP9 SP8 ZNF677 ZNF444 ZNF600 ZNF773 ZNF84 ZNF841 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 ZNF835 SP7 ZNF189 | 2.13e-17 | 775 | 41 | 20 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF787 ZNF737 SP5 SP9 SP8 ZNF677 ZNF444 ZNF600 ZNF773 ZNF84 ZNF841 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 ZNF835 SP7 ZNF189 | 2.24e-17 | 777 | 41 | 20 | PS00028 |
| Domain | Znf_C2H2-like | ZNF787 ZNF737 SP5 SP9 SP8 ZNF677 ZNF444 ZNF600 ZNF773 ZNF84 ZNF841 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 ZNF835 SP7 ZNF189 | 3.58e-17 | 796 | 41 | 20 | IPR015880 |
| Domain | Znf_C2H2 | ZNF787 ZNF737 SP5 SP9 SP8 ZNF677 ZNF444 ZNF600 ZNF773 ZNF84 ZNF841 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 ZNF835 SP7 ZNF189 | 4.45e-17 | 805 | 41 | 20 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF787 ZNF737 SP5 SP9 SP8 ZNF677 ZNF444 ZNF600 ZNF773 ZNF84 ZNF841 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 ZNF835 SP7 ZNF189 | 4.78e-17 | 808 | 41 | 20 | SM00355 |
| Domain | zf-C2H2_6 | ZNF787 ZNF737 ZNF677 ZNF600 ZNF773 ZNF84 ZNF841 ZNF486 ZNF606 ZNF157 ZNF160 | 5.14e-11 | 314 | 41 | 11 | PF13912 |
| Domain | KRAB | ZNF737 ZNF677 ZNF773 ZNF84 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 ZNF189 | 2.08e-10 | 358 | 41 | 11 | PS50805 |
| Domain | KRAB | ZNF737 ZNF677 ZNF773 ZNF84 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 ZNF189 | 2.08e-10 | 358 | 41 | 11 | PF01352 |
| Domain | KRAB | ZNF737 ZNF677 ZNF773 ZNF84 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 ZNF189 | 2.87e-10 | 369 | 41 | 11 | SM00349 |
| Domain | KRAB | ZNF737 ZNF677 ZNF773 ZNF84 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 ZNF189 | 2.95e-10 | 370 | 41 | 11 | IPR001909 |
| Domain | Sp1_fam | 4.16e-09 | 10 | 41 | 4 | IPR030450 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF737 ZNF677 ZNF600 ZNF773 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 FURIN SP7 ZNF189 | 4.44e-06 | 1387 | 32 | 13 | M734 |
| Pubmed | 2.54e-10 | 9 | 43 | 4 | 17509151 | ||
| Pubmed | Mammalian SP/KLF transcription factors: bring in the family. | 2.51e-08 | 25 | 43 | 4 | 15820306 | |
| Pubmed | 2.96e-06 | 181 | 43 | 5 | 37372979 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 15358670 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 26969725 | ||
| Pubmed | 9.78e-05 | 12 | 43 | 2 | 24475213 | ||
| Pubmed | Homeobox Gene Six3 is Required for the Differentiation of D2-Type Medium Spiny Neurons. | 1.15e-04 | 13 | 43 | 2 | 34014554 | |
| Pubmed | 1.15e-04 | 13 | 43 | 2 | 31001083 | ||
| Pubmed | 1.15e-04 | 13 | 43 | 2 | 31070778 | ||
| Pubmed | Replication of recently described type 2 diabetes gene variants in a South Indian population. | 1.15e-04 | 13 | 43 | 2 | 20580033 | |
| Pubmed | 1.56e-04 | 1285 | 43 | 8 | 35914814 | ||
| Pubmed | The transcription factor Zfp503 promotes the D1 MSN identity and represses the D2 MSN identity. | 2.01e-04 | 17 | 43 | 2 | 36081908 | |
| Pubmed | Dlx-dependent and -independent regulation of olfactory bulb interneuron differentiation. | 2.01e-04 | 17 | 43 | 2 | 17376983 | |
| Pubmed | 2.52e-04 | 19 | 43 | 2 | 23563609 | ||
| Pubmed | 2.52e-04 | 19 | 43 | 2 | 32156757 | ||
| Pubmed | Transcription Factors Sp8 and Sp9 Coordinately Regulate Olfactory Bulb Interneuron Development. | 2.52e-04 | 19 | 43 | 2 | 28981617 | |
| Pubmed | 2.52e-04 | 19 | 43 | 2 | 32234482 | ||
| Pubmed | 3.40e-04 | 22 | 43 | 2 | 19794065 | ||
| Pubmed | Sp9 Regulates Medial Ganglionic Eminence-Derived Cortical Interneuron Development. | 4.05e-04 | 24 | 43 | 2 | 29878134 | |
| Pubmed | Loss of Gsx1 and Gsx2 function rescues distinct phenotypes in Dlx1/2 mutants. | 4.40e-04 | 25 | 43 | 2 | 23042297 | |
| Pubmed | 5.14e-04 | 27 | 43 | 2 | 37995181 | ||
| Pubmed | 5.47e-04 | 305 | 43 | 4 | 21244100 | ||
| Pubmed | 5.53e-04 | 28 | 43 | 2 | 32868762 | ||
| Pubmed | 5.53e-04 | 28 | 43 | 2 | 30796806 | ||
| Pubmed | 5.53e-04 | 28 | 43 | 2 | 29967281 | ||
| Pubmed | Obesity and diabetes genetic variants associated with gestational weight gain. | 5.93e-04 | 29 | 43 | 2 | 20816152 | |
| Pubmed | Genetic interplay between the transcription factors Sp8 and Emx2 in the patterning of the forebrain. | 6.35e-04 | 30 | 43 | 2 | 17470284 | |
| Pubmed | 6.35e-04 | 30 | 43 | 2 | 31789450 | ||
| Pubmed | Dlx1/2-dependent expression of Meis2 promotes neuronal fate determination in the mammalian striatum. | 7.23e-04 | 32 | 43 | 2 | 35156680 | |
| Pubmed | Activation of beta-catenin signaling programs embryonic epidermis to hair follicle fate. | 7.69e-04 | 33 | 43 | 2 | 18480165 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 8.33e-04 | 908 | 43 | 6 | 19274049 | |
| Pubmed | 1.11e-03 | 638 | 43 | 5 | 31182584 | ||
| Interaction | SP9 interactions | 4.24e-06 | 2 | 42 | 2 | int:SP9 | |
| Interaction | ZNF519 interactions | 4.24e-06 | 2 | 42 | 2 | int:ZNF519 | |
| Interaction | SP8 interactions | 2.54e-05 | 4 | 42 | 2 | int:SP8 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF787 ZNF677 ZNF444 ZNF600 ZNF773 ZNF841 ZNF226 ZNF606 ZNF160 ZNF835 | 1.18e-07 | 1192 | 43 | 10 | chr19q13 |
| Cytoband | 19q13.43 | 1.40e-06 | 87 | 43 | 4 | 19q13.43 | |
| Cytoband | 19q13.41 | 2.46e-03 | 78 | 43 | 2 | 19q13.41 | |
| Cytoband | 2q31.1 | 2.85e-03 | 84 | 43 | 2 | 2q31.1 | |
| Cytoband | 19p12 | 3.26e-03 | 90 | 43 | 2 | 19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 5.89e-03 | 122 | 43 | 2 | chr19p12 | |
| Cytoband | 19q13.42 | 6.17e-03 | 125 | 43 | 2 | 19q13.42 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF787 ZNF737 SP5 SP9 SP8 ZNF677 ZNF444 ZNF600 ZNF773 ZNF84 ZNF841 ZNF486 ZNF226 ZNF519 ZNF606 ZNF157 ZNF160 ZNF835 SP7 ZNF189 | 1.06e-20 | 718 | 32 | 20 | 28 |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 1.01e-09 | 9 | 32 | 4 | 755 | |
| ToppCell | Control-Epithelial-Ionocyte|Epithelial / Disease state, Lineage and Cell class | 3.94e-07 | 155 | 43 | 5 | 4b9369b203a4d7071c56d3d8e6b450e9a0121c41 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 167 | 43 | 4 | e242827999caad08b0894d88ab97bc1df41b7650 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-05 | 180 | 43 | 4 | 310a311c3ed924c912a800cf287a825de44b8775 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 180 | 43 | 4 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-05 | 183 | 43 | 4 | f079179f2984def91ddf0b33d7949d5ecdbd380d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-05 | 183 | 43 | 4 | 49e8ee16e4f677f9f649e2a2faf1b9b16c5a27e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-05 | 185 | 43 | 4 | 6e7fefdd65d30abaffb26b92b0d04e1630d262ad | |
| ToppCell | VE-NK|VE / Condition, Cell_class and T cell subcluster | 3.85e-05 | 197 | 43 | 4 | cae6ff8763501e7a5897b50188ac2640d65a47c0 | |
| ToppCell | VE-NK-|VE / Condition, Cell_class and T cell subcluster | 3.85e-05 | 197 | 43 | 4 | ee89b8521fb4faaed9e4d39f7171e45eccf38b00 | |
| Disease | factor XI measurement, coronary artery disease | 1.98e-05 | 115 | 41 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | factor XI measurement | 5.25e-05 | 8 | 41 | 2 | EFO_0004694 | |
| Disease | factor XI measurement, Ischemic stroke | 2.53e-04 | 17 | 41 | 2 | EFO_0004694, HP_0002140 | |
| Disease | partial thromboplastin time | 5.10e-04 | 24 | 41 | 2 | EFO_0004310 | |
| Disease | factor VIII measurement, coronary artery disease | 5.24e-04 | 113 | 41 | 3 | EFO_0001645, EFO_0004630 | |
| Disease | antipsychotic drug related weight gain | 6.47e-04 | 27 | 41 | 2 | EFO_0004567 | |
| Disease | factor XI measurement, venous thromboembolism | 7.99e-04 | 30 | 41 | 2 | EFO_0004286, EFO_0004694 | |
| Disease | diastolic blood pressure, unipolar depression | 7.99e-04 | 30 | 41 | 2 | EFO_0003761, EFO_0006336 | |
| Disease | factor VIII measurement, venous thromboembolism | 1.03e-03 | 34 | 41 | 2 | EFO_0004286, EFO_0004630 | |
| Disease | chronic kidney disease, diabetic nephropathy | 1.15e-03 | 36 | 41 | 2 | EFO_0000401, EFO_0003884 | |
| Disease | coronary artery disease | 1.18e-03 | 1194 | 41 | 7 | EFO_0001645 | |
| Disease | HbA1c measurement | 2.34e-03 | 675 | 41 | 5 | EFO_0004541 | |
| Disease | diastolic blood pressure, alcohol consumption measurement | 2.58e-03 | 54 | 41 | 2 | EFO_0006336, EFO_0007878 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 2.77e-03 | 56 | 41 | 2 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | Insulin Sensitivity | 3.17e-03 | 60 | 41 | 2 | C0920563 | |
| Disease | Insulin Resistance | 3.17e-03 | 60 | 41 | 2 | C0021655 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 3.49e-03 | 63 | 41 | 2 | EFO_0001645, EFO_0004792 | |
| Disease | lymphocyte count | 3.73e-03 | 1464 | 41 | 7 | EFO_0004587 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HHERWKREGKLHNHG | 301 | A8MVM7 | |
| LHRHGDQAWGKHRRQ | 56 | Q6ZSB3 | |
| LKHTQRRHQGSHRWT | 21 | Q6JQN1 | |
| RRHQGSHRWTHLGGS | 26 | Q6JQN1 | |
| RISSGKAGTHWHQVR | 26 | Q7L5Y6 | |
| KDHRAGRGHQVHKSW | 606 | Q92619 | |
| KHRELKHSGSWPGHR | 671 | Q9P266 | |
| HTHGLSHLRGIFNWV | 126 | Q11130 | |
| RCSWKGSGLTHEAHR | 51 | Q641Q3 | |
| HFWHRGVTKRSLSPH | 66 | P09958 | |
| HRGMHTSLHLWNRSS | 6 | P32245 | |
| KEQGHTRRHDWGHEK | 421 | P01042 | |
| WGHEKQRKHNLGHGH | 431 | P01042 | |
| ENRRITGRAHWGSHH | 851 | Q96EK7 | |
| KDHHWSRGTLRHISE | 1216 | Q12923 | |
| AGVHSVGLTWIHKLH | 411 | Q99567 | |
| RGWAVGAARESTHHK | 496 | Q8WV44 | |
| THKHWDHSGGNRDLS | 171 | Q8N490 | |
| HTWRKHSRHPSGGNS | 176 | Q96D71 | |
| SHLKAHLRWHTGERP | 311 | Q6BEB4 | |
| DSHTHVSRQGAWKVH | 346 | O75159 | |
| DVHLGIAHTRWATHG | 86 | Q06210 | |
| TSHLKAHLRWHTGER | 346 | P0CG40 | |
| SHLKAHLRWHTGERP | 371 | Q8IXZ3 | |
| LRWHSSNLGKKIHDH | 291 | O15204 | |
| WKSHLIEHQRTHTGE | 271 | O75820 | |
| WREHLVRHRKTHSGA | 261 | Q8N0Y2 | |
| NSHLISHWRIHTGEK | 381 | Q9HCG1 | |
| RKAHLTEHQRTHIGW | 481 | P51786 | |
| WGSHLTQHQRVHTGE | 471 | Q8TB69 | |
| GKASHLKAHLRWHTG | 306 | Q8TDD2 | |
| SRKSHLISHWRTHTG | 301 | P51523 | |
| RSHLWGHQRTHTGEK | 471 | Q86XU0 | |
| SHKSSLINHWRVHTG | 341 | Q6PK81 | |
| IGWISHHDGHRVHKS | 206 | Q9NYT6 | |
| RSGLARHWSIHTGEK | 661 | Q6ZN19 | |
| LASHWRTHTGEKPHR | 181 | Q9Y2P0 | |
| SHISRGHQHQAWGSR | 21 | O95363 | |
| AWNSHLVRHTRIHSG | 396 | Q6ZNG1 | |
| AFTWSAGLHKHRRTH | 386 | Q96H40 | |
| RDGWSRVHNDHSHLG | 281 | Q9NWH7 | |
| SWTSHHIRDGIRHGL | 151 | Q0VDI3 | |
| SWNSHLIVHKRIHTG | 466 | Q8WXB4 | |
| SHLEGHRVTWTGRFK | 691 | O76024 | |
| NWSSHLTTHKRIHTG | 211 | O75373 | |
| SHWSKLTRHQRTHTG | 76 | Q6DD87 |